Related Experiment Video
Updated: Aug 19, 2026

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma
Abstract:
It has recently been suggested that topoisomerases could be important targets for several DNA intercalating drugs used in cancer therapy. This prompted us to purify and characterize a type II topoisomerase in a highly tumorigenic transplantable rabbit tumor isolated from a skin carcinoma associated with cottontail rabbit papillomavirus. We have found that the decatenating activity present in tumor cells was 40-100 times higher than that in the rabbit liver, while no activity could be found in skin extracts. The type II topoisomerases purified from tumor and liver cells consist of two subunits with molecular masses of about 160 kDa. The conditions of the reactions of relaxation, unknotting and decatenation catalyzed by these topoisomerases II were found to be similar to those observed with enzymes of other eukaryotic cells. In the course of the purification of the VX2 enzyme, we isolated and characterized a protein of about 30 kDa in whose presence the topoisomerase II was able to catenate very efficiently supercoiled DNA molecules. This protein has the same electrophoretic mobility as an H1-2 histone, and cross-reacts with an anti-H1 antiserum. The VX2 topoisomerase II as well as the VX2 tumor should constitute useful models for assays of antitumoral drugs.
Insights
Rabbit tumor cells exhibit significantly higher type II topoisomerase activity than liver cells, suggesting potential as a model for developing new cancer therapies targeting DNA intercalating drugs.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Topoisomerases are crucial enzymes involved in DNA replication and transcription.
- Type II topoisomerases are implicated as targets for DNA intercalating anticancer drugs.
- A highly tumorigenic rabbit tumor model (VX2) was utilized for enzyme characterization.
Purpose of the Study:
- To purify and characterize type II topoisomerase from a VX2 rabbit tumor.
- To compare the enzymatic activity of tumor-derived topoisomerase II with that from normal rabbit liver.
- To identify potential regulatory factors influencing topoisomerase II activity in cancer cells.
Main Methods:
- Isolation and purification of type II topoisomerase from VX2 tumor and rabbit liver cells.
- Assays for decatenating, relaxation, and unknotting activities.
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for molecular mass determination.
- Immunological cross-reactivity testing using anti-H1 antiserum.
Main Results:
- VX2 tumor cells displayed 40-100 times higher decatenating activity compared to rabbit liver.
- Type II topoisomerases from both tumor and liver consisted of ~160 kDa subunits.
- A ~30 kDa protein, identified as similar to H1-2 histone, was found to enhance DNA catenation by topoisomerase II.
Conclusions:
- The VX2 rabbit tumor exhibits significantly elevated type II topoisomerase activity, making it a relevant model for cancer research.
- The identified histone-like protein may play a role in regulating topoisomerase II function in tumorigenesis.
- The VX2 topoisomerase II and tumor model are valuable tools for screening novel antitumoral drugs.
More Related Videos
Related Concept Videos
DNA Helicases
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Telomeres and Telomerase
DNA Damage can Stall the Cell Cycle
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...

